Target intelligence / Profile preview

EHMT2 and SLC44A4 antisense RNA 1 (EHMT2-AS1)

Target: EHMT2-AS1
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

EHMT2-AS1 (EHMT2 and SLC44A4 antisense RNA 1) is a long non-coding RNA that is transcribed from the antisense strand of the EHMT2 and SLC44A4 gene loci. It is annotated in genomic databases as a non-protein coding RNA, but there is minimal published information on its specific biological functions, mechanisms of action, disease relevance, or potential as a therapeutic target[3]. No known drugs interact with EHMT2-AS1, and its role as a biomarker or in drug safety is currently undefined. Further research is required to elucidate its molecular and physiological roles.

Other names: EHMT2 antisense RNA 1 (non-protein coding)EHMT2-AS1

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on EHMT2 and SLC44A4 antisense RNA 1 (EHMT2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EHMT2 and SLC44A4 antisense RNA 1 (EHMT2-AS1).

Explore the full profile